Tower Research Capital LLC (Trc) Lantern Pharma Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,263 shares of LTRN stock, worth $4,483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,263
Previous 1,515
16.63%
Holding current value
$4,483
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding LTRN
# of Institutions
35Shares Held
2.48MCall Options Held
4.6KPut Options Held
600-
Bios Capital Management, LP Fort Worth, TX1.21MShares$4.29 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.29 Million0.0% of portfolio
-
Cm Management, LLC200KShares$710,0000.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny87.3KShares$309,9150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87KShares$308,7540.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $38.4M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...